Exscientia is a pharmaceutical technology company that automates drug design. The company is a drug discovery company that generates data before through the analytical power of artificial intelligence.
Exscientia has developed algorithms that have reduced the time for drug discovery and development by 70%. With their help, it was possible to create drugs for the treatment of oncological, immune and psychiatric diseases.
Now there are more than 25 drugs in the development of Exscientia. The most successful have gone from identifying a drug target to choosing a candidate for a drug in less than 1.5 years. When using conventional technologies, this process takes 4.5 years.
In September 2021, Exscientia received a $35 million investment from the Bill and Melinda Gates Foundation to develop a drug against COVID-19, influenza and other viruses that could cause a new pandemic.